Earnings season has been brutal for these 3 healthcare sector giants. The post Buy, hold, sell: CSL, Pro Medicus, Cochlear shares appeared first on The Motley Fool Australia.

A third ASX share Morgans has been looking at is online travel agent Webjet. It notes that takeover talks have ended and ...

ASX Healthcare lost 12% for week ending February 13, 2026 as Morgans' Scott Power said "it's brutal in the trenches" this reporting season.

The medical device maker expects full-year earnings to land near the bottom end of its forecast range, and has written down its investment in Saluda.

Cochlear grows sales revenue but posts lower profit in HY26. Dividend steady as Nexa implant launch impacts result. Read key ...

It looks set to be a poor finish to the week for Aussie investors. The post 5 things to watch on the ASX 200 on Friday appeared first on The Motley Fool Australia.

Explore Cochlear's strategies for managing revenue and margins as it prepares to release its HY 2026 earnings.

For some children, the world begins in silence. Words, music and even a parent’s voice arrive late or not at all, shaping how a child learns, connects and stays safe. For families across South Texas, ...

The U.S. Food and Drug Administration has approved an expanded indication for MED-EL (Medical Electronics) cochlear implants for children ages 7 months and older with bilateral sensorineural hearing ...

(CNN) — Ben Summers lights up with a smile the moment he talks about the “Batman” theme song or the afternoons he spends playing the piano at his grandmother’s house. Just a few years ago, Ben could ...